| Literature DB >> 35621571 |
Natwat Srikhao1, Korrapat Chirochrapas1, Nessaraporn Kwansanei1, Pornnapa Kasemsiri1, Artjima Ounkaew1, Manunya Okhawilai2,3, Chutiwat Likitaporn4, Somnuk Theerakulpisut5, Hiroshi Uyama6.
Abstract
Conventional drug delivery systems often cause side effects and gastric degradation. Novel drug delivery systems must be developed to decrease side effects and increase the efficacy of drug delivery. This research aimed to fabricate hydrogel beads for use as a drug delivery system based on basil seed mucilage (BSM), sodium alginate (SA), and magnetic particles (MPs). The Taguchi method and Grey relational analysis were used for the design and optimization of the hydrogel beads. Three factors, including BSM, SA, and MPs at four levels were designed by L-16 orthogonal arrays. BSM was the main factor influencing bead swelling, drug release rate at pH 7.4, and release of antioxidants at pH 1.2 and 7.4. In addition, SA and MPs mainly affected drug loading and drug release rate in acidic medium, respectively. Grey relational analysis indicated that the composition providing optimal overall properties was 0.2 vol% BSM, 0.8 vol% SA, and 2.25 vol% MPs. Based on the findings of this work, BSM/SA/MPs hydrogel beads have the potential to be used as a pH-sensitive alternative material for drug delivery in colon-specific systems.Entities:
Keywords: Grey relational analysis; Taguchi’s method; drug delivery system; hydrogel beads
Year: 2022 PMID: 35621571 PMCID: PMC9141934 DOI: 10.3390/gels8050274
Source DB: PubMed Journal: Gels ISSN: 2310-2861
Figure 1SEM images of hydrogel beads: (a) surface of sample from experimental design No. 4; (b) cross-section of sample from experimental design No. 4; (c) surface of sample from experimental design No. 16; and (d) cross-section of sample from experimental design No. 16.
Figure 2FTIR spectra of (a) chemical components and the BSM/SA/MPs hydrogel and (b) hydrogel beads loaded with diclofenac.
Figure 3(a) XRD pattern of MPs and (b) SEM images of MPs.
Figure 4Swelling (–●–) and S/N (–■–) ratios of the BSM/SA/MPs hydrogel beads.
ANOVA analysis results.
| Factor | DF a | SS b | MS c | F-Value | Contribution (%) | |
|---|---|---|---|---|---|---|
| Swelling | ||||||
| MPs | 3 | 87,231.00 | 29,077 | 5.97 | 0.031 | 15.33 |
| BSM | 3 | 387,831.00 | 129,277 | 26.56 | 0.001 | 68.17 |
| SA | 3 | 64,681.00 | 21,560 | 4.43 | 0.058 | 11.37 |
| Error | 6 | 29,200.00 | 4867 | - | - | 5.13 |
| Total | 15 | 568,944.00 | - | - | - | 100.00 |
| Drug loading | ||||||
| MPs | 3 | 0.0014 | 0.0005 | 0.29 | 0.830 | 3.31 |
| BSM | 3 | 0.0051 | 0.0017 | 1.07 | 0.429 | 12.14 |
| SA | 3 | 0.0259 | 0.0086 | 5.47 | 0.038 | 61.91 |
| Error | 6 | 0.0095 | 0.0016 | - | - | 22.64 |
| Total | 15 | 0.0418 | - | - | - | 100.00 |
| Release rate at pH 1.2 | ||||||
| MPs | 3 | 5.2066 | 1.7355 | 49.41 | 0.000 | 87.95 |
| BSM | 3 | 0.2119 | 0.0706 | 2.01 | 0.214 | 3.58 |
| SA | 3 | 0.2906 | 0.0969 | 2.76 | 0.134 | 4.91 |
| Error | 6 | 0.2108 | 0.0351 | - | - | 3.56 |
| Total | 15 | 5.9199 | - | - | - | 100.00 |
| Release rate at pH 7.4 | ||||||
| MPs | 3 | 7.9350 | 2.6450 | 0.86 | 0.513 | 16.58 |
| BSM | 3 | 10.8010 | 3.6000 | 1.16 | 0.398 | 22.56 |
| SA | 3 | 10.5900 | 3.5300 | 1.14 | 0.405 | 22.12 |
| Error | 6 | 18.5460 | 3.0910 | - | - | 38.74 |
| Total | 15 | 47.8720 | - | - | - | 100.00 |
| Antioxidant activity at pH 1.2 | ||||||
| MPs | 3 | 22.4500 | 7.4850 | 0.20 | 0.894 | 2.83 |
| BSM | 3 | 328.2000 | 109.4010 | 2.89 | 0.125 | 41.31 |
| SA | 3 | 216.6000 | 72.2010 | 1.91 | 0.230 | 27.26 |
| Error | 6 | 227.2300 | 37.8710 | - | - | 28.60 |
| Total | 15 | 794.4800 | - | - | - | 100.00 |
| Antioxidant activity at pH 7.4 | ||||||
| MPs | 3 | 126.9000 | 42.3000 | 0.510 | 0.690 | 12.10 |
| BSM | 3 | 280.3000 | 93.4200 | 1.12 | 0.411 | 26.73 |
| SA | 3 | 143.0000 | 47.6700 | 0.57 | 0.653 | 13.63 |
| Error | 6 | 498.7000 | 83.1100 | - | - | 47.55 |
| Total | 15 | 1048.8000 | - | - | - | 100.00 |
a Degree of freedom, b Sum of squares, c Mean square.
Figure 5Drug loading (–●–) and S/N ratio (–■–) of the BSM/SA/MPs hydrogel beads.
Figure 6Drug release at pH 1.2 (–●–) and S/N ratio (–■–) of the BSM/SA/MPs hydrogel beads.
Figure 7Drug release at pH 7.4 (–●–) and S/N ratio (–■–) of the BSM/SA/MPs hydrogel beads.
Figure 8Release of antioxidant at pH 1.2 (–●–) and S/N ratio (–■–) of the BSM/SA/MPs hydrogel beads.
Figure 9Release of antioxidant at pH 7.4 (–●–) and S/N ratio (–■–) of the BSM/SA/MPs hydrogel beads.
Results of confirmation experiment.
| Predicted | Experiment | |
|---|---|---|
| Grey relational grade | 0.720 | 0.584 |
Figure 10Release of drug from hydrogel at pH 1.2 and 7.4.
The fitting data of model drug release obtained with different mathematical models.
| Models | Parameters | PBS at pH 7.4 |
|---|---|---|
| Zero order |
| 387.400 ± 0.092 |
| R2 | 0.957 ± 0.076 | |
| First order |
| 1.106 ± 0.081 |
| R2 | 0.783 ± 0.109 | |
| Higuchi |
| 0.495 ± 0.095 |
| R2 | 0.875 ± 0.103 | |
| Kormeyer-Peppas |
| 0.215 ± 0.087 |
|
| 0.207 ± 0.098 | |
| R2 | 0.989 ± 0.097 |
Factors and their levels.
| Parameter | Level 1 | Level 2 | Level 3 | Level 4 |
|---|---|---|---|---|
| BSM (%vol) | 0.2 | 0.4 | 0.6 | 0.8 |
| SA (%vol) | 0.2 | 0.4 | 0.6 | 0.8 |
| MP (%vol) | 0.0 | 0.75 | 1.50 | 2.25 |
Taguchi experimental design.
| No. | Composition (%vol) | ||
|---|---|---|---|
| BSM | SA | MPs | |
| 1 | 0.2 | 0.2 | 0.0 |
| 2 | 0.4 | 0.4 | 0.0 |
| 3 | 0.6 | 0.6 | 0.0 |
| 4 | 0.8 | 0.8 | 0.0 |
| 5 | 0.4 | 0.2 | 0.75 |
| 6 | 0.2 | 0.4 | 0.75 |
| 7 | 0.8 | 0.6 | 0.75 |
| 8 | 0.6 | 0.8 | 0.75 |
| 9 | 0.6 | 0.2 | 1.50 |
| 10 | 0.8 | 0.4 | 1.50 |
| 11 | 0.2 | 0.6 | 1.50 |
| 12 | 0.4 | 0.8 | 1.50 |
| 13 | 0.8 | 0.2 | 2.25 |
| 14 | 0.6 | 0.4 | 2.25 |
| 15 | 0.4 | 0.6 | 2.25 |
| 16 | 0.2 | 0.8 | 2.25 |